OCUMENSION-B

01477

----

Current ValuationThe current P/E ratio is -29.99, below the reasonable range, cheaper than 94.1% of the time in the past 5 years, and the industry ranks 48/52, the industry Median 6.64.

-29.99xP/E

Stock priceHK$5.32Earnings per shareHK$-0.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 6.64x

010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 6.64x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
06887HKSUNSHINE PHARMA	-72.69x	--	HK$23.84B
02630HKVIGONVITA-B	-39.24x	--	HK$13.77B
09637HKALEBUND-B	-11.46x	48.48%	HK$9.29B
00570HKTRAD CHI MED	-5.19x	223.88%	HK$6.04B
02575HKXUANZHUBIO-B	-18.47x	--	HK$4.46B
01477HKOCUMENSION-B	-29.99x	52.80%	HK$4.33B
02652HKCF PHARMTECH	-380.27x	--	HK$2.97B
01349HKFUDANZHANGJIANG	-18.00x	--	HK$2.62B
02552HKHUA MEDICINE-B	-20.18x	104.78%	HK$2.50B
06622HKZHAOKE OPHTH-B	-5.50x	--	HK$1.36B
01011HKNT PHARMA	-23.21x	--	HK$736.59M
01652HKFUSEN PHARM	-257.18x	--	HK$687.55M
01643HKMODERN CHI MED	-9.10x	--	HK$439.20M
00455HKTIANDA PHARMA	-3.74x	--	HK$258.01M
00575HKREGENT PACIFIC	-15.64x	--	HK$239.29M
00858HKEXTRAWELL PHAR	-0.24x	--	HK$232.00M
01312HKKONTA CHINA	-0.87x	--	HK$184.42M
08329HKNEP INTERLONG	-2.54x	--	HK$154.38M
01498HKPURAPHARM	-4.75x	--	HK$131.29M
01889HKSANAI HEALTH GP	-1.29x	--	HK$29.05M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.